These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 34581725
1. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine. Borrelli E, Battista M, Cascavilla ML, Viganò C, Borghesan F, Nicolini N, Clemente L, Sacconi R, Barresi C, Marchese A, Miserocchi E, Modorati G, Bandello F, Querques G. Invest Ophthalmol Vis Sci; 2021 Sep 02; 62(12):28. PubMed ID: 34581725 [Abstract] [Full Text] [Related]
2. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY. Allahdina AM, Chen KG, Alvarez JA, Wong WT, Chew EY, Cukras CA. Retina; 2019 Mar 02; 39(3):473-484. PubMed ID: 30741731 [Abstract] [Full Text] [Related]
3. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity. Tsang A, Kanda P, Gottlieb C, Virgili G, Kantungane L, Coupland S. Doc Ophthalmol; 2022 Apr 02; 144(2):117-124. PubMed ID: 34762206 [Abstract] [Full Text] [Related]
4. Association between hydroxychloroquine intake and damage to the outer nuclear layer in eyes without manifest retinal toxicity. Salameh N, Doumit CA, Jalkh E, Nehme J. BMC Ophthalmol; 2024 Sep 27; 24(1):414. PubMed ID: 39334015 [Abstract] [Full Text] [Related]
5. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects. Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D. Br J Ophthalmol; 2019 Nov 27; 103(11):1600-1604. PubMed ID: 30819690 [Abstract] [Full Text] [Related]
6. Subjective and objective screening tests for hydroxychloroquine toxicity. Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL, Sieving PA. Ophthalmology; 2015 Feb 27; 122(2):356-66. PubMed ID: 25444344 [Abstract] [Full Text] [Related]
7. Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis. Telek HH, Yesilirmak N, Sungur G, Ozdemir Y, Yesil NK, Ornek F. Doc Ophthalmol; 2017 Dec 27; 135(3):187-194. PubMed ID: 28852896 [Abstract] [Full Text] [Related]
8. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study. Ruberto G, Bruttini C, Tinelli C, Cavagna L, Bianchi A, Milano G. Graefes Arch Clin Exp Ophthalmol; 2018 Nov 27; 256(11):2201-2210. PubMed ID: 30151601 [Abstract] [Full Text] [Related]
10. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity. Debellemanière G, Flores M, Tumahai P, Meillat M, Bidaut Garnier M, Delbosc B, Saleh M. Acta Ophthalmol; 2015 Nov 27; 93(7):e534-40. PubMed ID: 25989823 [Abstract] [Full Text] [Related]
11. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy. Ugwuegbu O, Uchida A, Singh RP, Beven L, Hu M, Kaiser S, Srivastava SK, Ehlers JP. Br J Ophthalmol; 2019 Jan 27; 103(1):3-7. PubMed ID: 30190364 [Abstract] [Full Text] [Related]
12. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations. Bulut M, Akıdan M, Gözkaya O, Erol MK, Cengiz A, Çay HF. Graefes Arch Clin Exp Ophthalmol; 2018 Nov 27; 256(11):2075-2081. PubMed ID: 30159602 [Abstract] [Full Text] [Related]
13. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. Tsang AC, Ahmadi S, Hamilton J, Gao J, Virgili G, Coupland SG, Gottlieb CC. Am J Ophthalmol; 2019 Oct 27; 206():132-139. PubMed ID: 31078540 [Abstract] [Full Text] [Related]
14. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy. Solberg Y, Dysli C, Möller B, Wolf S, Zinkernagel MS. Invest Ophthalmol Vis Sci; 2019 May 01; 60(6):2165-2172. PubMed ID: 31108547 [Abstract] [Full Text] [Related]
15. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy. Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC. Doc Ophthalmol; 2015 Feb 01; 130(1):13-23. PubMed ID: 25502494 [Abstract] [Full Text] [Related]
16. A possible early sign of hydroxychloroquine macular toxicity. Brandao LM, Palmowski-Wolfe AM. Doc Ophthalmol; 2016 Feb 01; 132(1):75-81. PubMed ID: 26792426 [Abstract] [Full Text] [Related]
17. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity. Allahdina AM, Stetson PF, Vitale S, Wong WT, Chew EY, Ferris FL, Sieving PA, Cukras C. Invest Ophthalmol Vis Sci; 2018 Apr 01; 59(5):1953-1963. PubMed ID: 29677357 [Abstract] [Full Text] [Related]
19. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS, Severns ML. Am J Ophthalmol; 2007 May 01; 143(5):801-809. PubMed ID: 17336914 [Abstract] [Full Text] [Related]